These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 31185471

  • 1. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ, Quigley CA, Cutler GB, Moore WV, Wintergerst KA, Ross JL, Rosenfeld RG, Blum WF.
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [Abstract] [Full Text] [Related]

  • 2. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A, González L, Gunczler P, Lanes R.
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [Abstract] [Full Text] [Related]

  • 3. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT, Elawwa A, Itani M, Jour C, De Sanctis V.
    Acta Biomed; 2019 Sep 23; 90(8-S):43-51. PubMed ID: 31544806
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 2009 Feb 23; 94(2):483-90. PubMed ID: 19001519
    [Abstract] [Full Text] [Related]

  • 5. Effect of growth hormone treatment on craniofacial growth in children: Idiopathic short stature versus growth hormone deficiency.
    Choi SH, Fan D, Hwang MS, Lee HK, Hwang CJ.
    J Formos Med Assoc; 2017 Apr 23; 116(4):313-321. PubMed ID: 27421175
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort.
    Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ibáñez L, Carlsson M, Cutfield W, Rooman R, Gomez R, Wajnrajch MP, Linglart A, Stawerska R, Clayton PE, Darendeliler F, Hokken-Koelega ACS, Horikawa R, Tanaka T, Dörr HG, Albertsson-Wikland K, Polak M, Grimberg A.
    J Clin Endocrinol Metab; 2022 Nov 25; 107(12):3287-3301. PubMed ID: 36102184
    [Abstract] [Full Text] [Related]

  • 10. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
    Lazar L, Levy S, Oron T, Meyerovitch J, de Vries L, Shalitin S, Tenenbaum A, Phillip M, Lebenthal Y.
    J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3287-3295. PubMed ID: 30912806
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenäs L, Ivarsson SA, Jonsson B, Kriström B, Marcus C, Nilsson KO, Ritzén EM, Tuvemo T, Westphal O, Aman J.
    J Clin Endocrinol Metab; 2008 Nov 01; 93(11):4342-50. PubMed ID: 18728172
    [Abstract] [Full Text] [Related]

  • 13. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Nov 01; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG).
    Clin Endocrinol (Oxf); 2012 Jul 01; 77(1):62-71. PubMed ID: 21950731
    [Abstract] [Full Text] [Related]

  • 15. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency.
    Frindik JP, Kemp SF, Hunold JJ.
    J Pediatr Endocrinol Metab; 2003 May 01; 16 Suppl 3():607-12. PubMed ID: 12795361
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.
    Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler S, Frane J, Lippe B.
    J Clin Endocrinol Metab; 2005 Sep 01; 90(9):5247-53. PubMed ID: 15998780
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of growth hormone treatment on height in children with idiopathic short stature.
    Jeong HR, Shim YS, Lee HS, Hwang JS.
    J Pediatr Endocrinol Metab; 2014 Jul 01; 27(7-8):629-33. PubMed ID: 24810558
    [Abstract] [Full Text] [Related]

  • 19. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R, Gunczler P, Esaa S, Weisinger JR.
    Clin Endocrinol (Oxf); 2002 Dec 01; 57(6):725-30. PubMed ID: 12460321
    [Abstract] [Full Text] [Related]

  • 20. Final adult height of children with idiopathic short stature: a multicenter study on GH therapy alone started during peri-puberty.
    Wu D, Chen RM, Chen SK, Liu GL, Chen LQ, Yang Y, Wang XL, Peng YG, Gong CX.
    BMC Pediatr; 2020 Mar 28; 20(1):138. PubMed ID: 32222149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.